Vir Biotechnology (VIR)
US Market

Vir Biotechnology (VIR) Stock Price & Analysis


VIR Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$18.05 - $34.97
Previous Close$30.14
Average Volume (3M)832.48K
Market CapN/A
Enterprise ValueN/A
Total Cash (Recent Filing)$2.35B
Total Debt (Recent Filing)$131.06M
Price to Earnings (P/E)3.5
Next EarningsFeb 23, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
EPS (TTM)8.50
Shares Outstanding133,115,621
Standard Deviation0.35
10 Day Avg. Volume911,374
30 Day Avg. Volume832,477
Price to Book (P/B)1.87
Price to Sales (P/S)2.49
Price to Cash Flow (P/CF)2.40
P/FCF Ratio2.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside90.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Vir Biotechnology’s price range in the past 12 months?
Vir Biotechnology lowest stock price was $18.05 and its highest was $34.97 in the past 12 months.
    What is Vir Biotechnology’s market cap?
    Currently, no data Available
    When is Vir Biotechnology’s upcoming earnings report date?
    Vir Biotechnology’s upcoming earnings report date is Feb 23, 2023 which is in 19 days.
      How were Vir Biotechnology’s earnings last quarter?
      Vir Biotechnology released its earnings results on Nov 03, 2022. The company reported $1.3 earnings per share for the quarter, beating the consensus estimate of -$0.508 by $1.808.
        Is Vir Biotechnology overvalued?
        According to Wall Street analysts Vir Biotechnology’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Vir Biotechnology pay dividends?
          Vir Biotechnology does not currently pay dividends.
          What is Vir Biotechnology’s EPS estimate?
          Vir Biotechnology’s EPS estimate is -$0.35.
            How many shares outstanding does Vir Biotechnology have?
            Vir Biotechnology has 133,115,620 shares outstanding.
              What happened to Vir Biotechnology’s price movement after its last earnings report?
              Vir Biotechnology reported an EPS of $1.3 in its last earnings report, beating expectations of -$0.508. Following the earnings report the stock price went up 17.706%.
                Which hedge fund is a major shareholder of Vir Biotechnology?
                Among the largest hedge funds holding Vir Biotechnology’s share is Gotham Asset Management LLC. It holds Vir Biotechnology’s shares valued at 1M.


                  Vir Biotechnology Stock Smart Score

                  The Vir Biotechnology stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Vir Biotechnology

                  Vir Biotechnology, Inc. engages in the provision of technologies to treat and prevent infectious diseases. Its technology platforms include antibody, T cell, innate immunity, and siRNA. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in 2016 and is headquartered in San Francisco, CA.


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Intellia Therapeutics

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis